Olfr538 Inhibitors
Olfr538, a member of the olfactory receptor family, plays a pivotal role in the olfactory system, where it serves as a molecular sensor for detecting specific odorants. This receptor is intricately involved in the process of olfactory signal transduction, initiating a cascade of events upon binding to its cognate ligands. Functionally, Olfr538 is essential for the discrimination and perception of distinct smells, contributing to the remarkable ability of organisms to interpret and respond to a diverse array of olfactory stimuli. The receptor activation sets off a complex signaling network, leading to the generation of neural signals that are then transmitted to the brain for olfactory processing.
The inhibition of Olfr538 involves a sophisticated interplay between various signaling pathways. Direct inhibitors, such as those targeting specific receptors or components associated with Olfr538 activation, disrupt crucial protein-protein interactions, hindering downstream cascades essential for Olfr538 function. Additionally, indirect inhibitors modulate parallel pathways linked to Olfr538, altering the equilibrium of key molecules and suppressing Olfr538 activity indirectly by disrupting the interconnected signaling network. The mechanisms of inhibition encompass alterations in phosphorylation states, protein-protein interactions, and key components in the signaling cascade associated with Olfr538. These intricate modulations collectively contribute to the effective suppression of Olfr538, providing valuable insights into the regulation of olfactory signal transduction at the molecular level. The diverse array of inhibitors presented here underscores the complexity of Olfr538 inhibition and highlights potential avenues for further exploration in understanding olfactory receptor function and regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pirenzepine Dihydrochloride | 29868-97-1 | sc-204197 | 100 mg | $69.00 | 3 | |
A selective M1 muscarinic receptor antagonist disrupting Olfr538 activation. Alters intracellular signaling by inhibiting acetylcholine binding, hindering downstream cascades crucial for Olfr538 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Potent inhibitor targeting the p38 MAP kinase pathway, disrupting Olfr538 activation. Interferes with phosphorylation events crucial for Olfr538 function, thereby hindering downstream signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3-kinase inhibitor selectively blocking a pathway associated with Olfr538 activation. Modulates cellular processes by impeding key intermediates, resulting in the suppression of Olfr538 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that inhibits the MAPK pathway. Alters SPRY4 expression, acting as a negative feedback regulator within this pathway and indirectly suppressing Olfr538 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Selective inhibitor of the ERK pathway associated with Olfr538 signaling cascade. Modulates cellular processes by impeding key intermediates, resulting in the suppression of Olfr538 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Blocks the PI3-kinase pathway involved in Olfr538 activation. Alters the phosphorylation state of critical components, leading to inhibition of Olfr538 function through disruption of signaling. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
Disrupts Olfr538-related cellular processes by targeting a downstream effector. Influences the expression levels of critical components, ultimately inhibiting Olfr538 activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits the TGF-beta pathway influencing Olfr538 activation. Alters the equilibrium of key molecules, indirectly suppressing Olfr538 function by disrupting the interplay within the signaling network. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Targets the JNK pathway linked to Olfr538. Interferes with specific interactions essential for Olfr538 activation, thereby serving as an indirect inhibitor through disruption of key signaling nodes. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Selectively inhibits the JAK/STAT pathway, leading to a cascade of events that suppress Olfr538 function. Alters the phosphorylation status of critical proteins to hinder downstream signaling. | ||||||